SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, OPNT, BNFT, ABMD

NEW YORK, Dec. 6, 2022

Elevate Credit, Inc. (NYSE: ELVT)'s sale to an affiliate of Park Cities Asset Management LLC for $1.87 per share. If you are an Elevate Credit shareholder, click here to learn more about your rights and options.

Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT)'s sale to Indivior PLC. Per the agreement, Indivior would acquire Opiant for $20.00 per share in cash, plus up to $8.00 per share in contingent value rights that may become payable in the event that certain net revenue milestones are achieved during the relevant seven-year period by OPNT003 after its approval and launch. If you are an Opiant shareholder, click here to learn more about your rights and options.

Benefitfocus, Inc. (NASDAQ: BNFT)'s sale to Voya Financial, Inc. for $10.50 per share. If you are a Benefitfocus shareholder, click here to learn more about your rights and options.

ABIOMED, Inc. (NASDAQ: ABMD)'s sale to Johnson & Johnson. Under the terms of the agreement, ABIOMED shareholders would receive $380.00 per share in cash and a non-tradeable contingent value right entitling the holder to receive up to $35.00 per share in cash if certain commercial and clinical milestones are achieved. If you are an ABIOMED shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.